sacubitril
Selected indexed studies
- Renal protection in chronic heart failure: focus on sacubitril/valsartan. (Eur Heart J Cardiovasc Pharmacother, 2021) [PMID:33822031]
- Sacubitril/valsartan: An antiarrhythmic drug? (J Cardiovasc Electrophysiol, 2022) [PMID:36069136]
- Sacubitril/Valsartan Off-Label Uses for Heart Failure. (J Card Fail, 2022) [PMID:35405341]
_Worker-drafted node — pending editorial review._
Connections
sacubitril is a side effect of
Sources
- The efficacy and safety of sacubitril/valsartan in chronic kidney disease: a systematic review and meta-analysis. (2024) pubmed
- Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study. (2022) pubmed
- Sacubitril/valsartan-induced liver injury: A case report and literature review. (2023) pubmed
- Sacubitril/valsartan: An antiarrhythmic drug? (2022) pubmed
- Efficacy of Sacubitril/Valsartan in Hypertension. (2022) pubmed
- Renal protection in chronic heart failure: focus on sacubitril/valsartan. (2021) pubmed
- Sacubitril/Valsartan Off-Label Uses for Heart Failure. (2022) pubmed
- Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure. (2024) pubmed
- Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome. (2023) pubmed
- Sacubitril-Valsartan. (2026) pubmed